Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fortun, Agnès
59  Ergebnisse:
Personensuche X
?
1

Excess of guide RNA reduces knockin efficiency and drastica..:

Chenouard, Vanessa ; Leray, Isabelle ; Tesson, Laurent...
iScience.  26 (2023)  4 - p. 106399 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Phase I/II clinical trial of adoptive cell transfer of sort..:

Dréno, Brigitte ; Khammari, Amir ; Fortun, Agnès...
Cancer Immunology, Immunotherapy.  70 (2021)  10 - p. 3015-3030 , 2021
Link: https://doi.org/10.1007/..
 
?
3

hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote ME..:

Charpentier, Maud ; Dupré, Emilie ; Fortun, Agnès...
Molecular Oncology.  16 (2021)  3 - p. 594-606 , 2021
Link: https://doi.org/10.1002/..
 
?
4

A novel and efficient approach to high-throughput productio..:

Vaurs, Juliette ; Douchin, Gaël ; Echasserieau, Klara...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Cancer vaccines: designing artificial synthetic long peptid..:

Rabu, Catherine ; Rangan, Laurie ; Florenceau, Laetitia...
OncoImmunology.  8 (2019)  4 - p. e1560919 , 2019
Link: https://doi.org/10.1080/..
 
?
6

TCR Analyses of Two Vast and Shared Melanoma Antigen-Specif..:

Simon, Sylvain ; Wu, Zhong ; Cruard, J....
Frontiers in Immunology.  9 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
7

IRES-dependent translation of the long non coding RNA meloe..:

Charpentier, Maud ; Croyal, Mikael ; Carbonnelle, Delphine...
Oncotarget.  7 (2016)  37 - p. 59704-59713 , 2016
Link: https://doi.org/10.18632..
 
?
8

Excess of guide RNA reduces knockin efficiency and drastica..:

Chenouard, Vanessa ; Leray, Isabelle ; Tesson, Laurent...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074149/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
9

A novel and efficient approach to high-throughput productio..:

Vaurs, Juliette ; Douchin, Gaël ; Echasserieau, Klara...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-021-96560-9.  , 2021
Link: https://inserm.hal.scien..
 
?
10

A novel and efficient approach to high-throughput productio..:

Vaurs, Juliette ; Douchin, Gaël ; Echasserieau, Klara...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-021-96560-9.  , 2021
Link: https://inserm.hal.scien..
 
?
11

A novel and efficient approach to high-throughput productio..:

Vaurs, Juliette ; Douchin, Gaël ; Echasserieau, Klara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390762/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Phase I/II clinical trial of adoptive cell transfer of sort..:

Dréno, Brigitte ; Khammari, Amir ; Fortun, Agnès...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-021-02961-0.  , 2021
Link: https://www.hal.inserm.f..
 
?
13

A novel and efficient approach to high-throughput productio..:

Vaurs, Juliette ; Douchin, Gaël ; Echasserieau, Klara...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-021-96560-9.  , 2021
Link: https://inserm.hal.scien..
 
?
14

Phase I/II clinical trial of adoptive cell transfer of sort..:

Dréno, Brigitte ; Khammari, Amir ; Fortun, Agnès...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423703/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Phase I/II clinical trial of adoptive cell transfer of sort..:

Dréno, Brigitte ; Khammari, Amir ; Fortun, Agnès...
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00262-021-02961-0.  , 2021
Link: https://inserm.hal.scien..
 
1-15